Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Comp01 is a code name for a topical corticosteroid lotion investigated primarily for dermatological conditions such as moderate plaque psoriasis and actinic keratosis. It has been used as an active comparator in clinical trials evaluating its safety and efficacy versus other topical treatments, including DFD01 spray. The mechanism of action is consistent with that of topical corticosteroids, which exert anti-inflammatory, antipruritic, and vasoconstrictive effects by modulating gene expression through glucocorticoid receptors in the skin. The specific chemical identity or active ingredient of Comp01 has not been publicly disclosed in available sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Comp01.